Daniel Pearson, MD
Pulmonary Disease · Dayton, OHNPI 1962708552
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $55,930 of the $61,312 with a category attached, or 91.2%. Regeneron Healthcare Solutions, Inc. accounts for 66.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $50,412 and has fallen 100.0% since, to $24 in 2022. Among pulmonary disease clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $901.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$41K
- Sanofi$20K
- Veran Medical Technologies, Inc.$790
- Supernus Pharmaceuticals, Inc.$51
- Pacira Pharmaceuticals Incorporated$24
- AbbVie$16
What the payments were for
- Consulting fees$1,5333%
- Speaking & faculty fees$55,93091%
- Travel & lodging$2,6214%
- Food & beverage$1,2282%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 36 | $40,722 |
| Sanofi | 24 | $19,710 |
| Veran Medical Technologies, Inc. | 3 | $790 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$61,312 in reported general payments places this provider in the 95th percentile of 571 pulmonary disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Dayton
- Thomas YungerDayton$353K
- Rajesh PatelDayton$54K
- Ravi DesaiDayton$34K
- Anuj GoyalDayton$28K
- Joseph KhabbazaAkron$655K
- Robert BaughmanCincinnati$640K
- Kristin HighlandCleveland$551K
- Bruce CorserCincinnati$502K
- Jason StieneckerLima$397K
- Mohammad SheattCincinnati$389K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.